Standard Contracts
Exhibit 10.16 CuraGen Corporation has omitted from this Exhibit 10.16 portions of the Agreement for which CuraGen Corporation has requested confidential treatment from the Securities and Exchange Commission. The portions of the Agreement for which...Confidential Treatment Agreement • March 13th, 1998 • Curagen Corp • Services-commercial physical & biological research
ContractConfidential Treatment Agreement • August 14th, 2006 • Neustar Inc • Communications services, nec
Pursuant to 17 CFR 240.24b-2, confidential information has been omitted in places marked “[* * *]” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application filed with the Commission.
AGREEMENT This Agreement (AGREEMENT) is entered into as of June 18, 2001 (EFFECTIVE DATE) between NeoGenesis, Inc., a Delaware corporation (NEOGENESIS) and Oxford GlycoSciences (UK) Limited (OGS), a company incorporated under the laws of England and...Confidential Treatment Agreement • February 5th, 2002 • Neogenesis Pharmaceuticals Inc • Pharmaceutical preparations • New York
Pursuant to 17 CFR 230.406, confidential information has been omitted in places marked “[* * *]” and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application filed with the Commission....Confidential Treatment Agreement • May 11th, 2005 • Neustar Inc • Communications services, nec • New York
THIS CONTRACTOR SERVICES AGREEMENT (“Agreement”) is made and entered into this 7th day of November, 1997 (“Effective Date”) by and between the Northeast Carrier Acquisition Company, L.L.C. (the “Customer”), a New York limited liability company, having offices at c/o Carville B. Collins, Piper & Marbury L.L.P., 36 South Charles Street, Baltimore, Maryland 21201 and Lockheed Martin IMS (“Contractor”), a New York corporation, having offices at 1200 K Street NW, 11th Floor, Washington, DC 20005.
Exhibit 10.15 THIS AGREEMENT made in duplicate as of this 9th day of August, 2000. BETWEEN:Confidential Treatment Agreement • March 29th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Ontario
Dated 5 March 2013 as amended pursuant to an amendment letter dated 19 March 2013 and a second amendment agreement dated 15 April 2013 and as amended and restated pursuant to a master amendment and restatement deed dated 21 May 2014 CARFIN FINANCE...Confidential Treatment Agreement • August 5th, 2014 • Avis Budget Group, Inc. • Services-auto rental & leasing (no drivers)
This Agreement is dated 5 March 2013 as amended pursuant to an amendment letter dated 19 March 2013 and a second amendment agreement dated 15 April 2013 and as amended and restated pursuant to a master amendment and restatement deed dated 21 May 2014 and made between:
AGREEMENTConfidential Treatment Agreement • February 5th, 2002 • Neogenesis Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Exhibit 10.24 CONFIDENTIAL TREATMENT REQUESTED THIS AGREEMENT is made and entered into this ____ day of May, 1997, by and between K.W.M., Inc., 1700 Broadway, New York, New York 10019 ("KW") and Full Moon & High Tide Productions, Inc. ("Lender"), c/o...Confidential Treatment Agreement • November 24th, 1997 • King World Productions Inc • Services-motion picture & video tape distribution • New York
